AAAAAA

   
Results: 1-10 |
Results: 10
Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology
Authors: Fetsch, PA Simsir, A Abati, A
Citation: Pa. Fetsch et al., Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology, DIAGN CYTOP, 25(3), 2001, pp. 158-161
Comparison of antibodies to MART-1 and MelanA in fine-needle aspiration samples of metastatic malignant melanoma
Authors: Fetsch, PA Filie, AC Steinberg, SM Abati, A
Citation: Pa. Fetsch et al., Comparison of antibodies to MART-1 and MelanA in fine-needle aspiration samples of metastatic malignant melanoma, DIAGN CYTOP, 25(1), 2001, pp. 78-79
Immunocytochemistry in effusion cytology - A contemporary review
Authors: Fetsch, PA Abati, A
Citation: Pa. Fetsch et A. Abati, Immunocytochemistry in effusion cytology - A contemporary review, CANC CYTOP, 93(5), 2001, pp. 293-308
Detection of circulating tumor cells and micrometastases in stage II, III,and IV breast cancer patients utilizing cytology and immunocytochemistry
Authors: Fetsch, PA Cowan, KH Weng, DE Freifield, A Filie, AC Abati, A
Citation: Pa. Fetsch et al., Detection of circulating tumor cells and micrometastases in stage II, III,and IV breast cancer patients utilizing cytology and immunocytochemistry, DIAGN CYTOP, 22(5), 2000, pp. 323-328
Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma - Fixation methods yield variable results
Authors: Fetsch, PA Riker, AI Marincola, FM Abati, A
Citation: Pa. Fetsch et al., Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma - Fixation methods yield variable results, CANC CYTOP, 90(4), 2000, pp. 252-257
Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?
Authors: Fetsch, PA Marincola, FM Abati, A
Citation: Pa. Fetsch et al., Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?, DIAGN CYTOP, 20(6), 1999, pp. 393-396
Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?
Authors: Fetsch, PA Marincola, FM Abati, A
Citation: Pa. Fetsch et al., Cytokeratin positivity in fine-needle aspirates of metastatic malignant melanoma: Fact or fiction?, DIAGN CYTOP, 20(4), 1999, pp. 249-252
The new melanoma markers: MART-1 and melan-A (the NIH experience)
Authors: Fetsch, PA Marincola, FM Abati, A
Citation: Pa. Fetsch et al., The new melanoma markers: MART-1 and melan-A (the NIH experience), AM J SURG P, 23(5), 1999, pp. 607-609
Anti-alpha-inhibin - Marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration
Authors: Fetsch, PA Powers, CN Zakowski, MF Abati, A
Citation: Pa. Fetsch et al., Anti-alpha-inhibin - Marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration, CANC CYTOP, 87(3), 1999, pp. 168-172
Melanoma-associated antigen recognized by T cells (MART-1) - The advent ofa preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration
Authors: Fetsch, PA Marincola, FM Filie, A Hijazi, YM Kleiner, DE Abati, A
Citation: Pa. Fetsch et al., Melanoma-associated antigen recognized by T cells (MART-1) - The advent ofa preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration, CANC CYTOP, 87(1), 1999, pp. 37-42
Risultati: 1-10 |